Skip to main content
NXL
NASDAQ Industrial Applications And Services

Nasdaq Delisting Looms for Nexalin Technology as Company Files Appeal

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.451
Mkt Cap
$9.729M
52W Low
$0.305
52W High
$2
52W Position info
48% above low
Off High info
77% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

NXL sits 48% above its 52-week low of $0.305 on light trading volume (0.3× avg).

Summary

Nexalin Technology received a Nasdaq delisting notice after failing to meet the $1.00 minimum bid price rule and is ineligible for a second compliance period due to insufficient stockholders' equity. The company has appealed, temporarily staying the delisting.


Key Events · Legal and Risk Events · NXL

  • Nasdaq Issues Delisting Notice

    On July 24, 2026, Nasdaq notified Nexalin that its common stock will be delisted on August 4, 2026, for failing to maintain a $1.00 minimum bid price.

  • Ineligible for Second Grace Period

    The company does not meet the $5 million minimum stockholders' equity requirement for a second 180-day compliance period, accelerating the delisting process.

  • Company Appeals, Staying Delisting

    Nexalin has requested a hearing before a Nasdaq Hearings Panel, which stays the suspension and delisting pending the Panel's decision.

  • Reverse Stock Split Still Pending

    The company previously sought shareholder approval for a reverse stock split to regain compliance; the outcome of that vote and the appeal will determine whether the stock remains listed.


Analysis · NXL · Industrial Applications And Services

A formal delisting notice from Nasdaq now puts Nexalin Technology on the clock: its stock is scheduled for removal on August 4, 2026, after the company failed to regain compliance with the $1.00 minimum bid price requirement. Because stockholders' equity falls below the $5 million initial listing threshold, a second grace period is off the table. The company has appealed the decision, which stays the delisting pending a hearing, but the outcome remains uncertain. This development sharply escalates the going-concern and listing risks that have been accumulating since the January 2026 deficiency notice and the recent proxy seeking approval for a reverse stock split.

At the time of this filing, NXL was trading at $0.45 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $9.7M. The 52-week trading range was $0.31 to $2.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NXL - Latest Insights

NXL
Jul 10, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $0.4496
Real-time Price: $0.4508 info
Change: +$0.0012 (+0.27%) info
Market Cap: $9.729M info
NXL
Jun 29, 2026, 5:30 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.3561
Real-time Price: $0.4508 info
Change: +$0.0947 (+27%) info
Market Cap: $9.729M info
NXL
Jun 23, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.3601
Real-time Price: $0.4508 info
Change: +$0.0907 (+25%) info
Market Cap: $9.729M info
NXL
Jun 10, 2026, 9:15 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.447
Real-time Price: $0.4508 info
Change: +$0.0038 (+0.85%) info
Market Cap: $9.729M info
NXL
Jun 04, 2026, 10:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.5588
Real-time Price: $0.4508 info
Change: -$0.108 (-19%) info
Market Cap: $9.729M info